Radiation & PRRT

In this webinar, Rebecca Hammond, Clinical Scientist at Royal Surrey County Hospital, explains peptide receptor radionuclide therapy (PRRT) for neuroendocrine cancer.

Rebecca covers how PRRT works, the role of lutetium-177, what patients can expect before, during and after treatment, and why radiation-safety precautions are needed. She also explains practical considerations including contact restrictions, hygiene, travel and follow-up.

Treatment arrangements and safety advice can vary between hospitals, so patients should always follow the guidance provided by their own treatment team.

Webinar recorded August 2026.

Lung Neuroendocrine Tumours (Carcinoid): Diagnosis, Treatment & Latest Research Explained

This educational presentation by Dr Gaurav Ahuja, Consultant in Respiratory Medicine at Royal Bolton Hospital, Bolton, UK, provides an overview of lung neuroendocrine tumours (lung carcinoids). The talk covers diagnosis, staging, treatment options, and the latest research, guiding patients and healthcare professionals through the journey from initial diagnosis to long-term care. It also highlights the importance of accurate diagnosis, multidisciplinary management, and recent advances aimed at improving patient outcomes.

Webinar recorded July 2026.

Nutrition for Neuroendocrine Tumours (NETs): Expert Dietitian Advice | Webinar

In this webinar, Niamh Brennan, Specialist Dietitian at King’s College Hospital NHS Foundation Trust, London, shares practical, evidence-based nutrition advice for people living with neuroendocrine tumours (NETs). Topics include healthy eating, managing digestive symptoms, pancreatic enzyme replacement therapy (PERT), vitamin supplementation, and debunking common diet myths to help support health and quality of life.

Webinar recorded June 2026.

Because every moment matters: A personalised approach to end-of-life care

This webinar, presented by Erica and Holly, Health and Wellbeing Cancer Nurse Specialists at NCUK, explores personalised end-of-life care and advance care planning. The session highlights the importance of making healthcare decisions with individuals, not for them, and discusses tools such as ReSPECT and Lasting Power of Attorney that can help ensure care reflects a person’s wishes, values, and priorities.

Webinar recorded May 2026.

NETWorking for Life: With the Power of Peer Support

This is the third webinar in the series from Neuroendocrine Cancer UK Ambassadors, exploring the realities of living and working with neuroendocrine cancer (NETs) and highlighting how the condition can affect careers, relationships, finances, mental health, and future plans. Through personal experiences, the session emphasises the importance of support from employers, loved ones, and the wider NETs community, while encouraging people to adapt, seek help when needed, and continue living positively alongside a long-term diagnosis.

Webinar recorded April 2026.

Research: why is it relevant to patients with NETs

This educational webinar from Neuroendocrine Cancer UK, recorded in April 2026, features Professor Jon Wadsley, Consultant Clinical Oncologist at Weston Park Cancer Centre and NIHR RDN National Speciality Lead for Cancer, discussing the importance of clinical research in improving outcomes for people living with neuroendocrine tumours (NETs). The session explores how clinical trials are designed and delivered, the different types of cancer research, how patients can access research opportunities, and the impact of landmark NET studies such as the NETTER-1 trial, which helped establish PRRT/Lutetium-177 as a standard treatment option.

Webinar recorded April 2026.

Somatostatin Analogues

This educational webinar, recorded in February 2026, features Nikie Jervis, NMC Registered Nurse and Director of Support Services & Policy at Neuroendocrine Cancer UK, providing an overview of neuroendocrine tumours (NETs), neuroendocrine carcinomas (NECs), and the role of somatostatin analogue therapy in treatment and symptom management. Nikie explains how the neuroendocrine system works, the differences between NETs and NECs, how treatments such as octreotide and lanreotide help control hormone symptoms and slow tumour growth, and the common side effects patients may experience, including gastrointestinal issues, blood sugar changes, malabsorption, and injection-site reactions.

Webinar recorded February 2026.

Beyond the Primary: Understanding Metastatic Neuroendocrine Cancer

In this webinar, Nikie Jervis (Director of Support Services and Policy and NMC Registered Nurse) explains what it means when neuroendocrine cancer spreads beyond the primary site. The session is aimed at helping patients and families better understand metastatic neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs).

Webinar recorded January 2026.

Diet and Nutrition for Neuroendocrine Cancer

Advanced Specialist Diabetes and Neuroendocrine Dietician, James Wimbury discusses common topics within diet and nutrition whilst living with neuroendocrine cancer.

Webinar recorded December 2025.

Visit our diet and nutrition page for further information.

NETWorking for Life – The power of peer support for those affected by neuroendocrine cancer

Neuroendocrine Cancer UK Ambassadors, Chrissie, Kath, Polly, Carolyn and Jon share their experiences of neuroendocrine cancer in this patient webinar ‘NETWorking for Life’.